Peliosis hepatis: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
|||
(5 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Peliosis hepatis}} | {{Peliosis hepatis}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{FH}}[[Adenike Eketunde]] | ||
{{ | |||
==[[Peliosis hepatis overview|Overview]]== | ==[[Peliosis hepatis overview|Overview]]== | ||
Line 33: | Line 31: | ||
==Case Studies== | ==Case Studies== | ||
[[Peliosis hepatis case study one|Case #1]] | [[Peliosis hepatis case study one|Case #1]] | ||
[[Category:Hepatology]] | [[Category:Hepatology]] |
Latest revision as of 14:41, 5 January 2021
Peliosis hepatis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Peliosis hepatis On the Web |
American Roentgen Ray Society Images of Peliosis hepatis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farwa Haideri [2]Adenike Eketunde
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Peliosis hepatis from Other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies